Among young women (<40), breast cancer incidence is higher among black women than white women, but at older ages, incidence is higher among white women than black women. The 'black-white crossover'in incidence has been interpreted as evidence of intrinsic biological differences in young, black women's breast cancer. In support of intrinsic biological differences in black vs. white tumors, our work in the Carolina Breast Cancer Study (CBCS), a large population-based case-control study that oversamples young African American (AA) women, demonstrated that young black women are more likely to get basal-like breast cancer (a poor prognosis cancer) and less likely to develop luminal breast cancer (the cancer with the best prognosis). However, we hypothesize that beyond intrinsic subtype (and within basal-like and luminal subtypes), there are additional biological differences in black vs. white tumors that arise due to ancestral differences in expression of genes involved in breast cancer progression. To understand the contribution of ancestry and race-related markers to cancer progression, it is important to (1) study expression and gene sequence differences in both tumor tissue and normal tissue, and (2) to identify the mechanistic implications of these expression differences in breast cancer and normal cells.
Aim 1 of this project will perform expression and gene sequence studies of tumor tissues to identify race-related changes that are also associated with cancer progression, while in Aim 2 the expression and gene sequence of normal tissue will be used to evaluate whether these progression-related genes differ prior to disease onset. These first two aims will use both tumor and normal tissues from two well characterized populations (Carolina Breast Cancer Study and the Normal Breast Study) with substantial proportions of African American patients. These biospecimens will be used to perform RNA-sequencing for quantitative gene expression, and gene sequence analysis, to identify race-associated gene expression differences and polymorphisms that contribute to cancer progression and mortality disparities. Having identified key expression and sequence differences, in Aim 3 will study these genes and their pathways in breast cell lines to evaluate their effects on normal morphogenesis and on cancer progression. The data from this project will identify new biological targets in race-associated breast cancer mortality and will identify the mechanisms by which race-associated gene expression differences promote tumor progression among African American women.
There is a significant disparity in breast cancer mortality, with young African American women having poor outcomes. While higher prevalence of basal-like breast cancers in this group of women is one contributor, there are likely additional race-related causative differences in gene expression even among breast cancers of a single subtype. Understanding the biological effects of these gene expression changes and their mechanistic effects could identify targets for addressing breast cancer mortality disparities.
|Feng, Ye; Rhie, Suhn Kyong; Huo, Dezheng et al. (2017) Characterizing Genetic Susceptibility to Breast Cancer in Women of African Ancestry. Cancer Epidemiol Biomarkers Prev 26:1016-1026|
|Huo, Dezheng; Hu, Hai; Rhie, Suhn K et al. (2017) Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas. JAMA Oncol 3:1654-1662|
|Williams, Lindsay A; Olshan, Andrew F; Hong, Chi-Chen et al. (2017) Alcohol Intake and Breast Cancer Risk in African American Women from the AMBER Consortium. Cancer Epidemiol Biomarkers Prev 26:787-794|
|Chollet-Hinton, Lynn; Anders, Carey K; Tse, Chiu-Kit et al. (2016) Breast cancer biologic and etiologic heterogeneity by young age and menopausal status in the Carolina Breast Cancer Study: a case-control study. Breast Cancer Res 18:79|
|Allott, Emma H; Geradts, Joseph; Sun, Xuezheng et al. (2016) Intratumoral heterogeneity as a source of discordance in breast cancer biomarker classification. Breast Cancer Res 18:68|
|Robinson, Whitney R; Nichols, Hazel B; Tse, Chiu Kit et al. (2016) Associations of Premenopausal Hysterectomy and Oophorectomy With Breast Cancer Among Black and White Women: The Carolina Breast Cancer Study, 1993-2001. Am J Epidemiol 184:388-99|
|Ruiz-Narváez, Edward A; Sucheston-Campbell, Lara; Bensen, Jeannette T et al. (2016) Admixture Mapping of African-American Women in the AMBER Consortium Identifies New Loci for Breast Cancer and Estrogen-Receptor Subtypes. Front Genet 7:170|
|Ruiz-Narváez, Edward A; Lunetta, Kathryn L; Hong, Chi-Chen et al. (2016) Genetic variation in the insulin, insulin-like growth factor, growth hormone, and leptin pathways in relation to breast cancer in African-American women: the AMBER consortium. NPJ Breast Cancer 2:|
|Zhu, Qianqian; Shepherd, Lori; Lunetta, Kathryn L et al. (2016) Trans-ethnic follow-up of breast cancer GWAS hits using the preferential linkage disequilibrium approach. Oncotarget 7:83160-83176|
|Williams, Lindsay A; Olshan, Andrew F; Tse, Chui Kit et al. (2016) Alcohol intake and invasive breast cancer risk by molecular subtype and race in the Carolina Breast Cancer Study. Cancer Causes Control 27:259-69|
Showing the most recent 10 out of 18 publications